ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 750341 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 750341; 2) Community: the network communities that were significantly associated with the response to NSC 750341; 3) Molecule: the relationships between components within communities and NSC 750341; 4) MDR: the compounds that were significantly associated with the NSC 750341.

NSC Compound Enrichment Correlation
NSC 721319 ((4-((6-Iodo-2-(2-thienyl)quinazolin-4-yl) amino)phenyl)sulfonyl)-2,5-thiazolylamine 0.0393863597626322 0.13926797
NSC 731621 Trans-N-{4-[N'-(4-fluorophenyl)hydrazinocarbonyl]cyclohexylm ethyl} -3,4-dichlorobenzenesulfonamide 0.0393863597626322 0.20105002
NSC 755443 Null 0.0406225271888773 -0.03525664
NSC 757113 METHOTREXATE(+/-) 0.0406225271888773 0.34315988
NSC 759228 IDEBENONE 0.0406225271888773 0.16942579
NSC 760181 9-(3-fluorobenzyl)-7-(3-fluorobenzyloxy)-2-(4-fluorobenzyl)-1-methyl-9H-beta-carbolinium bromide 0.0406225271888773 -0.0012548794
NSC 107124 Camptothecin Derivative 0.0406225271888776 0.23560903
NSC 112758 Rubomycin 0.0406225271888776 0.036723381
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.0406225271888776 0.35265921
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.0406225271888776 0.3127287
Total:151  Current:126    [First] [Prev] [Next] [Last]